LAURA QUAYE: Open Payments
NPI 1902299191 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$378 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $22 · 2025 $378
Food & beverage: $378
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $200 |
| Novo Nordisk Inc | 3 | $149 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Hologic Sales and Service, LLC | 1 | $14 |
Products named: Ozempic, CAPVAXIVE, ENFLONSIA, Rybelsus, SHINGRIX, APTIMA.
Industry payments across CA — which companies pay providers there.
